INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,138 | -6.2% | 289 | +20.9% | 0.00% | – |
| Q2 2023 | $9,746 | -9.2% | 239 | -17.0% | 0.00% | – |
| Q1 2023 | $10,734 | +76.8% | 288 | +65.5% | 0.00% | – |
| Q4 2022 | $6,071 | -39.3% | 174 | -2.2% | 0.00% | – |
| Q3 2022 | $10,000 | +11.1% | 178 | +0.6% | 0.00% | – |
| Q2 2022 | $9,000 | -35.7% | 177 | -11.5% | 0.00% | -100.0% |
| Q1 2022 | $14,000 | -41.7% | 200 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $24,000 | -33.3% | 199 | -24.9% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | +80.0% | 265 | +113.7% | 0.00% | 0.0% |
| Q2 2021 | $20,000 | +66.7% | 124 | -17.3% | 0.00% | 0.0% |
| Q1 2021 | $12,000 | +500.0% | 150 | +328.6% | 0.00% | – |
| Q4 2020 | $2,000 | -90.0% | 35 | -96.5% | 0.00% | -100.0% |
| Q3 2017 | $20,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |